Show simple item record

dc.contributor.authorCorazza, Ornella
dc.contributor.authorAssi, Sulaf
dc.contributor.authorSimonato, Pierluigi
dc.contributor.authorCorkery, John
dc.contributor.authorBersani, Saverio
dc.contributor.authorDemetrovics, Zsolt
dc.contributor.authorStair, Jacqueline
dc.contributor.authorFergus, Suzanne
dc.contributor.authorPezzolesi, Cinzia
dc.contributor.authorPasinetti, Manuela
dc.contributor.authorDeluca, Paolo
dc.contributor.authorDrummond, C.
dc.contributor.authorBlaszko, Ursula
dc.contributor.authorMoskalewicz, Jacek
dc.contributor.authorMervo, Barbara
dc.contributor.authorDi Furia, Lucia
dc.contributor.authorFarre, Magi
dc.contributor.authorFlesland, Liv
dc.contributor.authorPisarska, Agnieszka
dc.contributor.authorShapiro, Harry
dc.contributor.authorSiemann, Holger
dc.contributor.authorSkutle, Arvid
dc.contributor.authorSferrazza, Elias
dc.contributor.authorTorrens, Marta
dc.contributor.authorSambola, Farran
dc.contributor.authorvan der Kreeft, Peer
dc.contributor.authorScherbaum, Norbert
dc.contributor.authorSchifano, Fabrizio
dc.date.accessioned2013-09-04T14:00:06Z
dc.date.available2013-09-04T14:00:06Z
dc.date.issued2013-07-25
dc.identifier.citationCorazza , O , Assi , S , Simonato , P , Corkery , J , Bersani , S , Demetrovics , Z , Stair , J , Fergus , S , Pezzolesi , C , Pasinetti , M , Deluca , P , Drummond , C , Blaszko , U , Moskalewicz , J , Mervo , B , Di Furia , L , Farre , M , Flesland , L , Pisarska , A , Shapiro , H , Siemann , H , Skutle , A , Sferrazza , E , Torrens , M , Sambola , F , van der Kreeft , P , Scherbaum , N & Schifano , F 2013 , ' Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances (NPS) in the EU : the outcomes of the ReDNet project ' , Human Psychopharmacology: Clinical and Experimental , vol. 28 , no. 4 , pp. 317-323 . https://doi.org/10.1002/hup.2299
dc.identifier.issn0885-6222
dc.identifier.otherORCID: /0000-0002-7134-0665/work/70189314
dc.identifier.otherORCID: /0000-0001-7371-319X/work/98163967
dc.identifier.urihttp://hdl.handle.net/2299/11529
dc.description.abstractObjectives: The recent emergence of new psychoactive compounds (NPS) has raised prominent challenges in the fields of drug policy, substance use research, public health and service provision. The Recreational Drugs European Network (ReDNet) project, funded by the European Commission, was implemented to improve the information stream to young people and professionals about effects/risks of NPS identifying online products and disseminating relevant information through technological tools. Methods: Regular multilingual qualitative assessments of websites, drugs fora and other online resources were carried out using the Google search engine in 8 languages from collaborating countries. These included: the UK, Norway, Belgium, Germany, Hungary, Poland, Italy and Spain. Products were tested and prevention messages were developed and disseminated via technological tools such as interactive websites, SMS alert, social networking (Facebook, Twitter), Multimedia (You Tube), Smartphone applications (iPhone), and virtual learning environments (Second Life). Results: The ReDNet project established itself as the first Europe-wide prevention programme designed for NPS based on the efficacy of novel ICT-based forms of intervention. More than 650 NPS products and combinations were identified; relevant information was disseminated to target population and advice was given to both EU/ international agencies and national policy makers. Conclusions: Web monitoring activities are essential for mapping the diffusion of NPS and the use of technological tools can be successfully incorporated in specific prevention programmes. Furthermore, the involvement of multi-disciplinary international partnerships was and continues to be fundamental for responding to such a prominent challenge.en
dc.format.extent500248
dc.language.isoeng
dc.relation.ispartofHuman Psychopharmacology: Clinical and Experimental
dc.titlePromoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances (NPS) in the EU : the outcomes of the ReDNet projecten
dc.contributor.institutionCentre for Clinical Practice, Safe Medicines and Drug Misuse Research
dc.contributor.institutionPrescription and Illicit Drug Misuse
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionDepartment of Pharmacy
dc.contributor.institutionPatient and Medicines Safety
dc.contributor.institutionMedicinal and Analytical Chemistry
dc.contributor.institutionCentre for Research into Topical Drug Delivery and Toxicology
dc.contributor.institutionNanopharmaceutics
dc.contributor.institutionNatural Product Chemistry and Drug Design
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionCentre for Future Societies Research
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionCentre for Hazard Detection and Protection Research
dc.contributor.institutionCentre for Research in Mechanisms of Disease and Drug Discovery
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.1002/hup.2299
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record